Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
297.3 INR | -2.59% | -5.75% | -24.91% |
May. 22 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
May. 21 | Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.91% | 338M | |
+42.60% | 748B | |
+33.25% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.83% | 245B | |
+8.57% | 211B | |
-4.42% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- INDOCO Stock
- News Indoco Remedies Limited
- Transcript : Indoco Remedies Limited, Q2 2023 Earnings Call, Nov 11, 2022